Clinical Trials
5 trialsNCT05081882 2026-02-18
Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava
University of Florida
Phase 2 Active not recruiting
NCT00606502 2021-03-05
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
Spectrum Pharmaceuticals, Inc
Phase 2 Completed
NCT01885052 2019-12-09
Evaluation of National Cancer Institute Young Adult Stop-Smoking Program
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00321893 2016-01-25
Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00587353 2012-05-02
Tobacco Use Intervention Among Radiation Oncology Patients
Mayo Clinic
Phase 2 Completed